跳至主要内容
临床试验/IRCT20221202056689N1
IRCT20221202056689N1招募中3 期

Investigating the therapiotic effect of quince oxymel on treatment of non-alcoholic fatty liver disease - Randomized clinical Trial, triple Blinded, placebo controlled

Ghoum University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 65 years(—)
性别
All

入选标准

  • Patients between the ages of 20 and 65 years
  • are diagnosed with grade 2 or higher fatty liver based on the ultrasound report
  • liver enzymes that are higher than the normal level.

排除标准

  • Having diabetes
  • Viral hepatitis and autoimmune hepatitis
  • Having metabolic diseases such as Wilson's disease and hemochromatosis
  • History of alcohol consumption and alcoholic beverages
  • Liver transplant at some point in the past
  • Taking any type of medicine to treat fatty liver in the past one month
  • The patient's unwillingness to continue the plan
  • Severe allergy or drug complication
  • Pregnancy and breastfeeding
  • Taking Varfarin, heparin compounds and anticoagulant drugs

研究者

发起方
Ghoum University of Medical Sciences

相似试验